Triptolide - CAS 38748-32-2
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
Triptolide
Catalog Number:
38748-32-2
Synonyms:
PG490
CAS Number:
38748-32-2
Description:
Triptolide is a diterpene triepoxide, immunosuppresive agent extracted from the Chinese herb Tripterygium wilfordii.
Molecular Weight:
360.4
Molecular Formula:
C20H24O6
COA:
Inquire
MSDS:
Inquire
Tag:
ADCs Cytotoxin
Chemical Structure
CAS 38748-32-2 Triptolide

Related ADCs Cytotoxin Products


CAS 85079-48-7 Brevetoxin PbTx-3

Brevetoxin PbTx-3
(CAS: 85079-48-7)

An activator of voltage-sensitive Na+ channels, a suite of cyclic polyether compounds produced naturally by a species of dinoflagellate known as Karenia brevis....

CAS 21314-60-3 Pentazolone hydrochloride

Pentazolone hydrochloride
(CAS: 21314-60-3)

Synthetic, an inhibitor of monoamine oxydase.Enhances the toxicity of the Phenamine group and of Tryptamine.

CAS 4540-25-4 Fillalbin

Fillalbin
(CAS: 4540-25-4)

Tropane alkaloid, from plants of the Convolvulus genus,

CAS 135151-34-7 Katacine

Katacine
(CAS: 135151-34-7)

A proanthocyanidin from Polygonum coriaricum, an antihypoxic.

CAS 95506-56-2 Fasciculin 2

Fasciculin 2
(CAS: 95506-56-2)

Potent, reversible acetylcholinesterase inhibitor

CAS 5373-11-5 Cynaroside

Cynaroside
(CAS: 5373-11-5)

Cynaroside is a flavone, a flavonoid-like chemical compound. It is a 7-O-glucoside of luteolin.

CAS 26000-17-9 Lycoctonine

Lycoctonine
(CAS: 26000-17-9)

Lycoctonine is a plant alkaloid and a precursor to the ABC ring system of taxoids.

CAS 76862-65-2 α-conotoxin-GI

α-conotoxin-GI
(CAS: 76862-65-2)

α-conotoxin GI (alpha-conotoxin GI) is a conopeptide that has been isolated from the venom of the cone snail Conus geographus. α-conotoxin GI is a competitive a...

alpha-Dendrotoxin
(CAS: 74504-53-3)

α-Dendrotoxin inhibits 4-AP sensitive, inactivating voltage-gated<br/>K+ channels (KV1.1, KV1.2 and KV1.6).

CAS 94513-55-0 9,21-Dehydroryanodine

9,21-Dehydroryanodine
(CAS: 94513-55-0)

Potent inhibitor of Ca2+ release from sarcoplasmic reticulum

CAS 5008-52-6 Napelline

Napelline
(CAS: 5008-52-6)

Napelline is a diterpenoid alkaloid from plants of the Aconitum,genus, a potent antiarrhythmic with weak hypotensive and N-cholinoblocking effects.

Nanophine
(CAS: 5072-45-7)

Synthetic.alkaloid, a neuronal nicotinic AChR antagonist. Ganglioblocker.

CAS 90-47-1 Xanthone

Xanthone
(CAS: 90-47-1)

Xanthonoid Purified from Hypericum perforatum

CAS 40819-78-1 Methyllycaconitine Perchlorate

Methyllycaconitine Perchlorate
(CAS: 40819-78-1)

Potent antagonist for α7-containing neuronal nicotinic receptors (Ki = 1.4 nM). Interacts with α4β2 and α6β2 receptors at concentrations > 40 nM. Attenuates MET...

CAS 524-15-2 γ-Fagarine

γ-Fagarine
(CAS: 524-15-2)

A natural compound extracted from Phellodendron chinense, exhibits a near planar framework

CAS 149926-20-5 Atisine hydrochloride

Atisine hydrochloride
(CAS: 149926-20-5)

A potent antiarrhytmic and local anesthetic. Alkaloid , from plants of the Ranunculaceae family. Inhibitorand Enhancers of Uridine Diphosphate-Glucuronosyltrans...

CAS 491-70-3 Luteolin

Luteolin
(CAS: 491-70-3)

Anti-inflammatory, antioxidant and free radical scavenger. Inhibits LPS-induced TNF-α, IL-6 and inducible nitric oxide production and blocks NF-κB and AP-1 acti...

CAS 62996-74-1 Staurosporine

Staurosporine
(CAS: 62996-74-1)

Staurosporine is broad spectrum protein kinase inhibitor. Enzymes inhibited include protein kinase C (IC50 = 3 nM), protein kinase A (IC50 = 7 nM), p60v-src tyr...

Bucharidine
(CAS: 25865-94-5)

Quinoline Alkaloid Extracted from Haplophyllum bucharicum

CAS 79316-86-2 Tempidol hydrochloride

Tempidol hydrochloride
(CAS: 79316-86-2)

Potent ganglioblocker, a neuronal nicotinic AChR antagonist. .

Reference Reading


1. Total synthesis of novel D-ring-modified triptolide analogues: structure–cytotoxic activity relationship studies on the D-ring of triptolide
Bing Zhou, Xiaomei Li, Huanyu Tang, Zehong Miao, Huijin Feng and Yuanchao Li*. Org. Biomol. Chem., 2011, 9, 3176–3179
For a long time, there have been no studies on the structure-activity relationship of the D-ring of triptolide except for two patents, describing some butenolide-modified triptolide analogues without any biological activity data, and our previous paper, reporting that an analogue (compound 6) with a five-membered unsaturated lactam ring has the same activity as the natural triptolide. So the structure-activity relationship of the D-ring is still obscure. To explore whether the five-membered unsaturated lactone ring of triptolide is completely critical to its anticancer activity, compound 3,havinga transposition butenolide, compound 4,which has a furan ring replacing the five-membered unsaturated lactone ring, and compound 5 without the planar D-ring were synthesized for SAR studies of the D-ring. The SAR studies of these tripolide analogues were performed by using ovary (SK-OV-3) and prostate (PC-3) tumor cells.
2. Computational prediction and experimental validation of low-affinity target of triptolide and its analogues
Xiufeng Liu, Kai Wang, Weijuan Zheng,* Jiahuang Li* and Zi-chun Hua*. RSC Adv.,2015, 5,34572–34579
This study was designed to investigate the potential interactions between NRs and triptolide, triptonide and triptriolide. 12 NRs were first screened through docking calculations to identify the putative molecular targets of triptolide. Then themost likely target ERa-LBD was expressed and purified in vitro. The binding capacities between ERa-LBD and three compounds were determined by Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC) analyses. The results were further validated using reporter gene assays. These data revealed ERa act as a previously unknown binding protein of triptolide and triptonide which may provide valuable information for studying the mechanisms and structure–function relationships of these chemicals in vivo.
3. The role of breast cancer resistance protein (Bcrp/Abcg2) in triptolide-induced testis toxicity
Chunzhu Li, Guozhen Xing, Xinming Qi,* Guangji Wang*. Toxicol. Res.,2015, 4,1260–1268
Preclinical studies have revealed that triptolide has strong effects against cancer, collagen-induced arthritis, skin allograft rejection and bone marrow transplantation. Several derivatives of triptolide have entered human clinical trials for cancer and other diseases. However, the clinical uses of triptolide and its derivatives have been limited by their toxicity. Triptolide induced cumulative testis toxicity in some experimental and clinical research studies. The mechanisms of testicular injury induced by triptolide are not characterized well.